Marshall Wace
TDOC icon

Marshall Wace’s Teladoc Health TDOC Stock Holding History

Marshall Wace’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,000
Closed -$16.4K – 3739
2026
Q1 		$16.4K Hold
3,000
– – ﹤0.01% 3066
2025
Q4 		$21K Buy
+3,000
New +$23.5K ﹤0.01% 2824

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Marshall Wace's TDOC Position: Q2 2026 in Review

Marshall Wace reduced its Teladoc Health (TDOC) stake by 83% in Q2 2026, selling an estimated $2.3M and leaving 73,292 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

Marshall Wace first reported a position in TDOC in Q4 2020 and has held it in 15 quarters since. The position peaked at $112M in Q1 2022. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Marshall Wace held 73,292 shares of Teladoc Health worth $622K as of Q2 2026.
  • Marshall Wace sold 346,282 Teladoc Health shares in Q2 2026, an estimated $2.3M.
  • Teladoc Health made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2421 holding.
  • Marshall Wace first reported a position in Teladoc Health in Q4 2020 and has held it in 15 quarters since.
  • Marshall Wace's Teladoc Health position peaked at $112M in Q1 2022.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.